Navigation Links
SleepRight Nasal Breathe Aid Now Available in CVS Caremark
Date:9/3/2013

Kansas City, Missouri (PRWEB) September 03, 2013

“This is a very exciting time for SleepRight,” said Rick Haxton, National Sales Manager for Splintek. “Our customers are looking for long-term solutions to help them sleep better and we have the answer. Now that SleepRight Nasal Breathe Aids are available at their local CVS pharmacy, they can quickly get the help they need to sleep better at night and wake up rejuvenated.”

Splintek, Inc., the creators of the SleepRight NO-BOIL® Dental Guard, designed the revolutionary SleepRight Nasal Breathe Aid, which offers an innovative solution to reduce snoring and relieve nasal congestion. The SleepRight Nasal Breathe Aid helps open a deviated septum and enhances overall breathing performance by increasing oxygen levels. The SleepRight Nasal Breathe Aid’s flexible design gently expands nasal passages to increase airflow and promote a healthy night’s sleep without using skin-pulling adhesives. Each breathe aid is reusable and lasts up to 15 days.

###

Splintek, Inc. is located in Kansas City, Missouri and has been designing health and comfort products since 1996. Splintek owns and operates the SleepRight product line including SleepRight Nasal Breathe Aid, SleepRight Dental Guard, SleepRight Tongue Cleaner, and SleepRight Side Sleeping Pillow. All products are available in the USA and select pharmacies in Canada. For more information call 888.792.0865 or visit http://www.sleepright.com.

Copyright © 2013 Splintek, Inc. SleepRight® and NO-BOIL® are registered trademarks of Splintek, Inc.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11075509.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Study: No link between depression, nasal obstruction
2. Steroid Nasal Sprays Show Small Benefit for Sinusitis: Study
3. An advance toward a flu-fighting nasal spray
4. Swallowing Nasal Sprays, Eye Drops Can Harm Kids, FDA Warns
5. Teva to present new Phase III data for QNASL® Nasal Aerosol at the 2012 ACAAI Meeting
6. Overdose education, bystander nasal naloxone rescue kits associated with decreased opioid overdose death
7. Nasal Polyps Treatment
8. How “Nasal Polyps Treatment Miracle” Helps People Treat Nasal Polyps – V-kool
9. Dr. Philip Miller Now Performing MicroRhinoplasty for Nasal Hump Reduction
10. Pregnant Women Who Use Nasal Decongestants During the First Trimester May Increase Their Babies’ Risks of Birth Defects; Parker Waichman LLP Is Evaluating Legal Claims
11. Orange County Facial Plastic Surgeon Talks about Sport Related Nasal Injuries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... ... LLC (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions ... definitive agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... ... this summer’s edition of “Vision & Hearing,” advocating for active, healthy lifestyles and ... on resources available for individuals with hearing impairments and shares the latest innovations ...
(Date:8/18/2017)... , ... August 18, 2017 , ... ... handling handheld devices. Through an educational webinar, they will present the line of ... chance to learn how easy you can automate everyday pipetting tasks. , Ideal ...
(Date:8/18/2017)... ... August 18, 2017 , ... Hernandez Insurance Agencies, a northern ... the greater DC region, is inaugurating a “New Leash On Life” charity initiative ... training them to be companions for veterans in need. , The Semper K9 ...
(Date:8/18/2017)... ... 18, 2017 , ... Moore Insurance, a Houston area agency ... is launching a regional charity effort to provide publicity assistance and generate donations ... Tumor Foundation (PBTF) has raised nearly $30 million in donations that has been ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), ... ended June 30, 2017, and updated its financial outlook ... For the fiscal third quarter, Hill-Rom reported earnings ... diluted share in the prior-year period. These results reflect ... diluted share primarily related to the non-cash write-down of ...
(Date:7/27/2017)... July 27, 2017  West Pharmaceutical Services, Inc. (NYSE: ... for the second-quarter 2017 and updated financial guidance for ... Second-Quarter 2017 Highlights Reported net sales ... the prior-year quarter. Net sales at constant currency (organic) ... EPS was $0.51, compared to $0.60 in the prior-year ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
Breaking Medicine Technology: